These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38103822)

  • 1. A review of the conservative versus invasive management of ischemic heart failure with reduced ejection fraction.
    Matta A; Ohlmann P; Nader V; Levai L; Kang R; Carrié D; Roncalli J
    Curr Probl Cardiol; 2024 Feb; 49(2):102347. PubMed ID: 38103822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-Analysis.
    Wolff G; Dimitroulis D; Andreotti F; Kołodziejczak M; Jung C; Scicchitano P; Devito F; Zito A; Occhipinti M; Castiglioni B; Calveri G; Maisano F; Ciccone MM; De Servi S; Navarese EP
    Circ Heart Fail; 2017 Jan; 10(1):. PubMed ID: 28087687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial.
    Pölzl L; Nägele F; Graber M; Hirsch J; Lobenwein D; Mitrovic M; Mayr A; Theurl M; Schreinlechner M; Pamminger M; Dorfmüller C; Grimm M; Gollmann-Tepeköylü C; Holfeld J
    Trials; 2020 May; 21(1):447. PubMed ID: 32473644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STICH3C: Rationale and Study Protocol.
    Fremes SE; Marquis-Gravel G; Gaudino MFL; Jolicoeur EM; Bédard S; Masterson Creber R; Ruel M; Vervoort D; Wijeysundera HC; Farkouh ME; Rouleau JL;
    Circ Cardiovasc Interv; 2023 Aug; 16(8):e012527. PubMed ID: 37582169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an update.
    Nägele F; Pölzl L; Graber M; Hirsch J; Mayr A; Pamminger M; Troger F; Theurl M; Schreinlechner M; Sappler N; Dorfmüller C; Mitrovic M; Ulmer H; Grimm M; Gollmann-Tepeköylü C; Holfeld J
    Trials; 2022 Dec; 23(1):988. PubMed ID: 36494706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
    Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
    JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlled.
    Iannaccone M; Barbero U; Franchin L; Montabone A; De Filippo O; D'ascenzo F; Boccuzzi G; Panoulas V; Hill J; Brilakis ES; Chieffo A
    Int J Cardiol; 2024 Feb; 396():131428. PubMed ID: 37820779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary revascularization for patients with severe left ventricular dysfunction.
    Nagendran J; Norris CM; Graham MM; Ross DB; Macarthur RG; Kieser TM; Maitland AM; Southern D; Meyer SR;
    Ann Thorac Surg; 2013 Dec; 96(6):2038-44. PubMed ID: 23968761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
    Perera D; Clayton T; O'Kane PD; Greenwood JP; Weerackody R; Ryan M; Morgan HP; Dodd M; Evans R; Canter R; Arnold S; Dixon LJ; Edwards RJ; De Silva K; Spratt JC; Conway D; Cotton J; McEntegart M; Chiribiri A; Saramago P; Gershlick A; Shah AM; Clark AL; Petrie MC;
    N Engl J Med; 2022 Oct; 387(15):1351-1360. PubMed ID: 36027563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting on Clinical Outcomes in Patients with Reduced Ejection Fraction Heart Failure and Coronary Heart Disease: A Meta-Analysis.
    Yu ZX; Yan J; Wang MY; Chen R; Luo JY; Li XM; Xie X; Ma YT
    Heart Surg Forum; 2023 Feb; 26(1):E062-E073. PubMed ID: 36856505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization in Ischemic Heart Failure with Reduced Left Ventricular Ejection Fraction.
    Gasior P; Wojakowski W; Kedhi E
    Curr Cardiol Rep; 2023 May; 25(5):401-409. PubMed ID: 37010802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
    Parikh PB; Bhatt DL; Bhasin V; Anker SD; Skopicki HA; Claessen BE; Fonarow GC; Hernandez AF; Mehran R; Petrie MC; Butler J
    J Am Coll Cardiol; 2021 May; 77(19):2432-2447. PubMed ID: 33985688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial.
    Thuijs DJFM; Milojevic M; Stone GW; Puskas JD; Serruys PW; Sabik JF; Dressler O; Crowley A; Head SJ; Kappetein AP
    Eur J Heart Fail; 2020 May; 22(5):871-879. PubMed ID: 32043709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
    Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
    Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
    Marui A; Kimura T; Nishiwaki N; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Eur J Cardiothorac Surg; 2015 Feb; 47(2):316-21; discussion 321. PubMed ID: 24662243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.